Michael David Geschwind - Publications

Affiliations: 
University of California, San Francisco, San Francisco, CA 
Area:
prions, dementia, rapidly progressive dementia, Jakob-Creutzfeldt disease, autoimmune encephalopathy

81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Schmitz M, Villar-Piqué A, Hermann P, Escaramís G, Calero M, Chen C, Kruse N, Cramm M, Golanska E, Sikorska B, Liberski PP, Pocchiari M, Lange P, Stehmann C, Sarros S, ... ... Geschwind MD, et al. Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases. Brain : a Journal of Neurology. PMID 35288744 DOI: 10.1093/brain/awab350  0.302
2020 Jones E, Hummerich H, Viré E, Uphill J, Dimitriadis A, Speedy H, Campbell T, Norsworthy P, Quinn L, Whitfield J, Linehan J, Jaunmuktane Z, Brandner S, Jat P, Nihat A, ... ... Geschwind MD, et al. Identification of novel risk loci and causal insights for sporadic Creutzfeldt-Jakob disease: a genome-wide association study. The Lancet. Neurology. 19: 840-848. PMID 32949544 DOI: 10.1016/S1474-4422(20)30273-8  0.331
2020 Yang CY, Lai RY, Amokrane N, Lin CY, Figueroa KP, Pulst SM, Perlman S, Wilmot G, Gomez CM, Schmahmann JD, Paulson H, Shakkottai VG, Rosenthal LS, Ying SH, Zesiewicz T, ... ... Geschwind M, et al. Dysphagia in spinocerebellar ataxias type 1, 2, 3 and 6. Journal of the Neurological Sciences. 415: 116878. PMID 32454319 DOI: 10.1016/J.Jns.2020.116878  0.366
2020 Gan SR, Figueroa KP, Xu HL, Perlman S, Wilmot G, Gomez CM, Schmahmann J, Paulson H, Shakkottai VG, Ying SH, Zesiewicz T, Bushara K, Geschwind MD, Xia G, Subramony SH, et al. The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism & Related Disorders. 72: 37-43. PMID 32105964 DOI: 10.1016/J.Parkreldis.2020.02.004  0.413
2019 Ngo KJ, Rexach JE, Lee H, Petty LE, Perlman S, Valera JM, Deignan JL, Mao Y, Aker M, Posey JE, Jhangiani SN, Coban-Akdemir ZH, Boerwinkle E, Muzny D, Nelson AB, ... ... Geschwind MD, et al. A Diagnostic Ceiling for Exome Sequencing in Cerebellar Ataxia and Related Neurological Disorders. Human Mutation. PMID 31692161 DOI: 10.1002/Humu.23946  0.357
2019 Aguilar-Calvo P, Sevillano AM, Bapat J, Soldau K, Sandoval DR, Altmeppen HC, Linsenmeier L, Pizzo DP, Geschwind MD, Sanchez H, Appleby BS, Cohen ML, Safar JG, Edland SD, Glatzel M, et al. Shortening heparan sulfate chains prolongs survival and reduces parenchymal plaques in prion disease caused by mobile, ADAM10-cleaved prions. Acta Neuropathologica. PMID 31673874 DOI: 10.1007/S00401-019-02085-X  0.323
2019 Minikel EV, Vallabh SM, Orseth MC, Brandel JP, Haïk S, Laplanche JL, Zerr I, Parchi P, Capellari S, Safar J, Kenny J, Fong JC, Takada LT, Ponto C, Hermann P, ... ... Geschwind MD, et al. Age at onset in genetic prion disease and the design of preventive clinical trials. Neurology. PMID 31171647 DOI: 10.1212/Wnl.0000000000007745  0.365
2019 Staffaroni AM, Kramer AO, Casey M, Kang H, Rojas JC, Orrú CD, Caughey B, Allen IE, Kramer JH, Rosen HJ, Blennow K, Zetterberg H, Geschwind MD. Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease. Jama Neurology. PMID 31058916 DOI: 10.1001/Jamaneurol.2019.1071  0.323
2019 Vallabh SM, Nobuhara CK, Llorens F, Zerr I, Parchi P, Capellari S, Kuhn E, Klickstein J, Safar JG, Nery FC, Swoboda KJ, Geschwind MD, Zetterberg H, Arnold SE, Minikel EV, et al. Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development. Proceedings of the National Academy of Sciences of the United States of America. PMID 30936307 DOI: 10.1073/Pnas.1901947116  0.332
2019 Vitali P, Palesi F, Cotta Ramusino M, Pan M, Costa A, Gandini Wheeler-Kingshott C, Ceroni M, Micieli G, Anzalone N, Giaccone G, Tagliavini F, Geschwind M. Early cortical and late striatal diffusion restriction on 3T MRI in a long-lived sporadic creutzfeldt-jakob disease case. Journal of Magnetic Resonance Imaging : Jmri. PMID 30912188 DOI: 10.1002/Jmri.26711  0.312
2019 Lai RY, Tomishon D, Figueroa KP, Pulst SM, Perlman S, Wilmot G, Gomez CM, Schmahmann JD, Paulson H, Shakkottai VG, Ying SH, Zesiewicz T, Bushara K, Geschwind M, Xia G, et al. Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor. Cerebellum (London, England). PMID 30830673 DOI: 10.1007/S12311-019-01016-6  0.387
2018 Villar-Piqué A, Schmitz M, Lachmann I, Karch A, Calero O, Stehmann C, Sarros S, Ladogana A, Poleggi A, Santana I, Ferrer I, Mitrova E, Žáková D, Pocchiari M, Baldeiras I, ... ... Geschwind MD, et al. Cerebrospinal Fluid Total Prion Protein in the Spectrum of Prion Diseases. Molecular Neurobiology. PMID 30062673 DOI: 10.1007/S12035-018-1251-1  0.396
2018 Geschwind MD, Murray K. Differential diagnosis with other rapid progressive dementias in human prion diseases. Handbook of Clinical Neurology. 153: 371-397. PMID 29887146 DOI: 10.1016/B978-0-444-63945-5.00020-9  0.424
2018 Ngo K, Aker M, Petty LE, Chen J, Cavalcanti F, Nelson AB, Hassin-Baer S, Geschwind MD, Perlman S, Italiano D, Laganà A, Cavallaro S, Coppola G, Below JE, Fogel BL. Expanding the global prevalence of spinocerebellar ataxia type 42. Neurology. Genetics. 4: e232. PMID 29629410 DOI: 10.1212/Nxg.0000000000000232  0.353
2017 Kuo PH, Gan SR, Wang J, Lo RY, Figueroa KP, Tomishon D, Pulst SM, Perlman S, Wilmot G, Gomez CM, Schmahmann JD, Paulson H, Shakkottai VG, Ying SH, Zesiewicz T, ... ... Geschwind MD, et al. Dystonia and ataxia progression in spinocerebellar ataxias. Parkinsonism & Related Disorders. PMID 29089256 DOI: 10.1016/J.Parkreldis.2017.10.007  0.304
2017 Kim MO, Takada LT, Wong K, Forner SA, Geschwind MD. Genetic PrP Prion Diseases. Cold Spring Harbor Perspectives in Biology. PMID 28778873 DOI: 10.1101/Cshperspect.A033134  0.4
2017 Erkkinen MG, Kim MO, Geschwind MD. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harbor Perspectives in Biology. PMID 28716886 DOI: 10.1101/Cshperspect.A033118  0.423
2017 Takada LT, Kim MO, Cleveland RW, Wong K, Forner SA, Gala II, Fong JC, Geschwind MD. Genetic prion disease: Experience of a rapidly progressive dementia center in the United States and a review of the literature. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 174: 36-69. PMID 27943639 DOI: 10.1002/Ajmg.B.32505  0.38
2016 Luo L, Wang J, Lo RY, Figueroa KP, Pulst SM, Kuo PH, Perlman S, Wilmot G, Gomez CM, Schmahmann JD, Paulson H, Shakkottai VG, Ying SH, Zesiewicz T, Bushara K, ... Geschwind M, et al. The Initial Symptom and Motor Progression in Spinocerebellar Ataxias. Cerebellum (London, England). PMID 27848087 DOI: 10.1007/S12311-016-0836-3  0.338
2016 Kim H, Kim JH, Possin KL, Winer J, Geschwind MD, Xu D, Hess CP. Surface-based morphometry reveals caudate subnuclear structural damage in patients with premotor Huntington disease. Brain Imaging and Behavior. PMID 27730480 DOI: 10.1007/S11682-016-9616-4  0.31
2016 Fong JC, Rojas JC, Bang J, Legati A, Rankin KP, Forner S, Miller ZA, Karydas AM, Coppola G, Grouse CK, Ralph J, Miller BL, Geschwind MD. Genetic Prion Disease Caused by PRNP Q160X Mutation Presenting with an Orbitofrontal Syndrome, Cyclic Diarrhea, and Peripheral Neuropathy. Journal of Alzheimer's Disease : Jad. PMID 27716661 DOI: 10.3233/Jad-160300  0.381
2016 Geschwind MD, Paras N. Deutetrabenazine for Treatment of Chorea in Huntington Disease. Jama. 316: 33-5. PMID 27380339 DOI: 10.1001/Jama.2016.8011  0.33
2016 Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Höftberger R, Iizuka T, Irani SR, et al. A clinical approach to diagnosis of autoimmune encephalitis. The Lancet. Neurology. PMID 26906964 DOI: 10.1016/S1474-4422(15)00401-9  0.337
2015 Savard M, Irani SR, Guillemette A, Gosselin-Lefebvre S, Geschwind M, Jansen GH, Gould PV, Laforce R. Creutzfeldt-Jakob Disease-Like Periodic Sharp Wave Complexes in Voltage-Gated Potassium Channel-Complex Antibodies Encephalitis: A Case Report. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. PMID 26375660 DOI: 10.1097/Wnp.0000000000000171  0.326
2015 Tousseyn T, Bajsarowicz K, Sánchez H, Gheyara A, Oehler A, Geschwind M, DeArmond B, DeArmond SJ. Prion Disease Induces Alzheimer Disease-Like Neuropathologic Changes. Journal of Neuropathology and Experimental Neurology. 74: 873-888. PMID 26226132 DOI: 10.1097/Nen.0000000000000228  0.356
2015 Cali I, Miller CJ, Parisi JE, Geschwind MD, Gambetti P, Schonberger LB. Distinct pathological phenotypes of Creutzfeldt-Jakob disease in recipients of prion-contaminated growth hormone. Acta Neuropathologica Communications. 3: 37. PMID 26108478 DOI: 10.1186/S40478-015-0214-2  0.362
2015 Kim MO, Geschwind MD. Clinical update of Jakob-Creutzfeldt disease. Current Opinion in Neurology. 28: 302-10. PMID 25923128 DOI: 10.1097/Wco.0000000000000197  0.424
2015 Lo RY, Figueroa KP, Pulst SM, Lin CY, Perlman S, Wilmot G, Gomez C, Schmahmann J, Paulson H, Shakkottai VG, Ying S, Zesiewicz T, Bushara K, Geschwind M, Xia G, et al. Coenzyme Q10 and spinocerebellar ataxias. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 214-20. PMID 25449974 DOI: 10.1002/Mds.26088  0.303
2015 Hurth K, Tarawneh R, Ghoshal N, Benzinger TL, Clifford DB, Geschwind M, Morris JC, Galvin JE, Schmidt RE, Cairns NJ. Whipple's disease masquerades as dementia with Lewy bodies. Alzheimer Disease and Associated Disorders. 29: 85-9. PMID 23995819 DOI: 10.1097/Wad.0B013E3182A715Da  0.38
2014 Caverzasi E, Mandelli ML, DeArmond SJ, Hess CP, Vitali P, Papinutto N, Oehler A, Miller BL, Lobach IV, Bastianello S, Geschwind MD, Henry RG. White matter involvement in sporadic Creutzfeldt-Jakob disease. Brain : a Journal of Neurology. 137: 3339-54. PMID 25367029 DOI: 10.1093/Brain/Awu298  0.301
2014 Minikel EV, Zerr I, Collins SJ, Ponto C, Boyd A, Klug G, Karch A, Kenny J, Collinge J, Takada LT, Forner S, Fong JC, Mead S, Geschwind MD. Ascertainment bias causes false signal of anticipation in genetic prion disease. American Journal of Human Genetics. 95: 371-82. PMID 25279981 DOI: 10.1016/J.Ajhg.2014.09.003  0.363
2014 Irani SR, Gelfand JM, Bettcher BM, Singhal NS, Geschwind MD. Effect of rituximab in patients with leucine-rich, glioma-inactivated 1 antibody-associated encephalopathy. Jama Neurology. 71: 896-900. PMID 24842754 DOI: 10.1001/Jamaneurol.2014.463  0.301
2014 Caverzasi E, Henry RG, Vitali P, Lobach IV, Kornak J, Bastianello S, Dearmond SJ, Miller BL, Rosen HJ, Mandelli ML, Geschwind MD. Application of quantitative DTI metrics in sporadic CJD. Neuroimage. Clinical. 4: 426-35. PMID 24624328 DOI: 10.1016/J.Nicl.2014.01.011  0.347
2014 Uflacker A, Doraiswamy PM, Rechitsky S, See T, Geschwind M, Tur-Kaspa I. Preimplantation Genetic Diagnosis (PGD) for Genetic Prion Disorder Due to F198S Mutation in the PRNP Gene Jama Neurology. 71: 484-486. PMID 24493558 DOI: 10.1001/Jamaneurol.2013.5884  0.342
2014 Geschwind MD. Doxycycline for Creutzfeldt-Jakob disease: a failure, but a step in the right direction. The Lancet. Neurology. 13: 130-2. PMID 24411710 DOI: 10.1016/S1474-4422(14)70001-8  0.348
2014 You SC, Geschwind MD, Sha SJ, Apple A, Satris G, Wood KA, Johnson ET, Gooblar J, Feuerstein JS, Finkbeiner S, Kang GA, Miller BL, Hess CP, Kramer JH, Possin KL. Executive functions in premanifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 405-9. PMID 24375511 DOI: 10.1002/Mds.25762  0.322
2014 Uflacker A, Doraiswamy M, Rechitsky S, See T, Geschwind M, Tur-Kaspa I. Preimplantation Genetic Diagnosis for a Genetic Prion Disease American Journal of Geriatric Psychiatry. 22. DOI: 10.1016/J.Jagp.2013.12.076  0.319
2013 Kim MO, Cali I, Oehler A, Fong JC, Wong K, See T, Katz JS, Gambetti P, Bettcher BM, Dearmond SJ, Geschwind MD. Genetic CJD with a novel E200G mutation in the prion protein gene and comparison with E200K mutation cases. Acta Neuropathologica Communications. 1: 80. PMID 24330864 DOI: 10.1186/2051-5960-1-80  0.343
2013 Ashizawa T, Figueroa KP, Perlman SL, Gomez CM, Wilmot GR, Schmahmann JD, Ying SH, Zesiewicz TA, Paulson HL, Shakkottai VG, Bushara KO, Kuo SH, Geschwind MD, Xia G, Mazzoni P, et al. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet Journal of Rare Diseases. 8: 177. PMID 24225362 DOI: 10.1186/1750-1172-8-177  0.357
2013 Bechtel K, Geschwind MD. Ethics in prion disease. Progress in Neurobiology. 110: 29-44. PMID 23906487 DOI: 10.1016/J.Pneurobio.2013.07.001  0.384
2013 Vossel KA, Beagle AJ, Rabinovici GD, Shu H, Lee SE, Naasan G, Hegde M, Cornes SB, Henry ML, Nelson AB, Seeley WW, Geschwind MD, Gorno-Tempini ML, Shih T, Kirsch HE, et al. Seizures and epileptiform activity in the early stages of Alzheimer disease. Jama Neurology. 70: 1158-66. PMID 23835471 DOI: 10.1001/Jamaneurol.2013.136  0.341
2013 Biglan KM, Zhang Y, Long JD, Geschwind M, Kang GA, Killoran A, Lu W, McCusker E, Mills JA, Raymond LA, Testa C, Wojcieszek J, Paulsen JS. Refining the diagnosis of Huntington disease: the PREDICT-HD study. Frontiers in Aging Neuroscience. 5: 12. PMID 23565093 DOI: 10.3389/Fnagi.2013.00012  0.313
2013 Lee SE, Tartaglia MC, Yener G, Genç S, Seeley WW, Sanchez-Juan P, Moreno F, Mendez MF, Klein E, Rademakers R, López de Munain A, Combarros O, Kramer JH, Kenet RO, Boxer AL, ... Geschwind MD, et al. Neurodegenerative disease phenotypes in carriers of MAPT p.A152T, a risk factor for frontotemporal dementia spectrum disorders and Alzheimer disease. Alzheimer Disease and Associated Disorders. 27: 302-9. PMID 23518664 DOI: 10.1097/Wad.0B013E31828Cc357  0.416
2013 Johnson DY, Dunkelberger DL, Henry M, Haman A, Greicius MD, Wong K, DeArmond SJ, Miller BL, Gorno-Tempini ML, Geschwind MD. Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia. Jama Neurology. 70: 254-7. PMID 23400721 DOI: 10.1001/2013.Jamaneurol.139  0.445
2013 McIntyre D, Geschwind M, Zerr I, Metz R, Droste D, Diederich N, Beyenburg S. Report on cluster of three autopsy confirmed cases of sporadic Creutzfeldt–/INS;Jakob disease from Luxembourg including videos, imaging, genetics and neuropathology Journal of the Neurological Sciences. 333. DOI: 10.1016/J.Jns.2013.07.1277  0.312
2012 Paterson RW, Torres-Chae CC, Kuo AL, Ando T, Nguyen EA, Wong K, DeArmond SJ, Haman A, Garcia P, Johnson DY, Miller BL, Geschwind MD. Differential diagnosis of Jakob-Creutzfeldt disease. Archives of Neurology. 69: 1578-82. PMID 23229042 DOI: 10.1001/2013.Jamaneurol.79  0.401
2012 Coppola G, Chinnathambi S, Lee JJ, Dombroski BA, Baker MC, Soto-Ortolaza AI, Lee SE, Klein E, Huang AY, Sears R, Lane JR, Karydas AM, Kenet RO, Biernat J, Wang LS, ... ... Geschwind MD, et al. Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases. Human Molecular Genetics. 21: 3500-12. PMID 22556362 DOI: 10.1093/Hmg/Dds161  0.368
2012 Tartaglia MC, Johnson DY, Thai JN, Cattaruzza T, Wong K, Garcia P, Dearmond SJ, Miller BL, Geschwind MD. Clinical overlap between Jakob-Creutzfeldt disease and Lewy body disease. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 39: 304-10. PMID 22547509 DOI: 10.1017/S0317167100013421  0.345
2012 Forner S, Wong K, Bostrom A, Takada L, Tartaglia C, Haman A, Torres-Chae C, Raudabaugh B, Devereux G, Miller B, Geschwind M. CSF Biomarkers Findings in a Large Rapidly Progressive Dementia Cohort (S14.004) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S14.004  0.305
2012 Tartaglia C, Lee S, Geschwind M, Perry D, Afaisen S, Khan B, Wu T, Rodriguez H, Ketelle R, Steele J, Miller B. Neuropsychiatric Features of Parkinsonism Dementia Complex and Other Neurodegenerative Diseases on Guam (P05.040) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.040  0.411
2012 Lee S, Tartaglia C, Geschwind M, Perry D, Afaisen S, Wu T, Khan B, Steele J, Miller B. Hetereogeneity of Neurodegenerative Diseases on Guam (P05.037) Neurology. 78. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.037  0.373
2011 Perry DC, Geschwind MD. Thorough work-up and new diagnostic criteria needed for CJD. Nature Reviews. Neurology. 7: 479-80. PMID 21892213 DOI: 10.1038/Nrneurol.2011.118  0.361
2011 Lee SE, Rabinovici GD, Mayo MC, Wilson SM, Seeley WW, DeArmond SJ, Huang EJ, Trojanowski JQ, Growdon ME, Jang JY, Sidhu M, See TM, Karydas AM, Gorno-Tempini ML, Boxer AL, ... ... Geschwind MD, et al. Clinicopathological correlations in corticobasal degeneration. Annals of Neurology. 70: 327-40. PMID 21823158 DOI: 10.1002/Ana.22424  0.375
2011 Vitali P, Maccagnano E, Caverzasi E, Henry RG, Haman A, Torres-Chae C, Johnson DY, Miller BL, Geschwind MD. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology. 76: 1711-9. PMID 21471469 DOI: 10.1212/Wnl.0B013E31821A4439  0.341
2010 Tartaglia MC, Thai JN, See T, Kuo A, Harbaugh R, Raudabaugh B, Cali I, Sattavat M, Sanchez H, DeArmond SJ, Geschwind MD. Pathologic evidence that the T188R mutation in PRNP is associated with prion disease. Journal of Neuropathology and Experimental Neurology. 69: 1220-7. PMID 21107135 DOI: 10.1097/Nen.0B013E3181Ffc39C  0.407
2010 Benetti F, Geschwind MD, Legname G. De novo prions. F1000 Biology Reports. 2. PMID 20948787 DOI: 10.3410/B2-46  0.335
2010 Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I, Shimoji M, Langeveld JP, Castellani R, Notari S, Crain B, Schmidt RE, Geschwind M, Dearmond SJ, Cairns NJ, et al. Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Annals of Neurology. 68: 162-72. PMID 20695009 DOI: 10.1002/Ana.22094  0.388
2010 Yang TI, Jung DS, Ahn BY, Jeong BH, Cho HJ, Kim YS, Na DL, Geschwind MD, Kim EJ. Familial Creutzfeldt-Jakob disease with V180I mutation. Journal of Korean Medical Science. 25: 1097-100. PMID 20592908 DOI: 10.3346/Jkms.2010.25.7.1097  0.377
2010 Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, et al. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Archives of Neurology. 67: 154-60. PMID 20142523 DOI: 10.1001/Archneurol.2009.334  0.317
2009 Rosenbloom MH, Smith S, Akdal G, Geschwind MD. Immunologically mediated dementias. Current Neurology and Neuroscience Reports. 9: 359-67. PMID 19664365 DOI: 10.1007/S11910-009-0053-2  0.35
2009 Choi EM, Geschwind MD, Deering C, Pomeroy K, Kuo A, Miller BL, Safar JG, Prusiner SB. Prion proteins in subpopulations of white blood cells from patients with sporadic Creutzfeldt-Jakob disease. Laboratory Investigation; a Journal of Technical Methods and Pathology. 89: 624-35. PMID 19434060 DOI: 10.1038/Labinvest.2009.30  0.303
2009 Geschwind MD. Clinical trials for prion disease: difficult challenges, but hope for the future. The Lancet. Neurology. 8: 304-6. PMID 19278901 DOI: 10.1016/S1474-4422(09)70050-X  0.426
2009 Geschwind MD, Potter CA, Sattavat M, Garcia PA, Rosen HJ, Miller BL, DeArmond SJ. Correlating DWI MRI with pathologic and other features of Jakob-Creutzfeldt disease. Alzheimer Disease and Associated Disorders. 23: 82-87. PMID 19266702 DOI: 10.1097/Wad.0B013E31818323Ef  0.34
2008 Geschwind MD, Tan KM, Lennon VA, Barajas RF, Haman A, Klein CJ, Josephson SA, Pittock SJ. Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Archives of Neurology. 65: 1341-6. PMID 18852349 DOI: 10.1001/Archneur.65.10.1341  0.402
2008 Vitali P, Migliaccio R, Agosta F, Rosen HJ, Geschwind MD. Neuroimaging in dementia. Seminars in Neurology. 28: 467-83. PMID 18843575 DOI: 10.1055/S-0028-1083695  0.37
2008 Webb TE, Poulter M, Beck J, Uphill J, Adamson G, Campbell T, Linehan J, Powell C, Brandner S, Pal S, Siddique D, Wadsworth JD, Joiner S, Alner K, Petersen C, ... ... Geschwind MD, et al. Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain : a Journal of Neurology. 131: 2632-46. PMID 18757886 DOI: 10.1093/Brain/Awn202  0.406
2008 Geschwind MD, Shu H, Haman A, Sejvar JJ, Miller BL. Rapidly progressive dementia. Annals of Neurology. 64: 97-108. PMID 18668637 DOI: 10.1002/Ana.21430  0.356
2008 Valcour V, Haman A, Cornes S, Lawall C, Parsa AT, Glaser C, Yagi S, Tihan T, Bhatnagar J, Geschwind M. A case of enteroviral meningoencephalitis presenting as rapidly progressive dementia. Nature Clinical Practice. Neurology. 4: 399-403. PMID 18477991 DOI: 10.1038/Ncpneuro0804  0.351
2007 Geschwind MD, Haman A, Miller BL. Rapidly progressive dementia. Neurologic Clinics. 25: 783-807, vii. PMID 17659190 DOI: 10.1016/J.Ncl.2007.04.001  0.322
2007 Boxer AL, Rabinovici GD, Kepe V, Goldman J, Furst AJ, Huang SC, Baker SL, O'neil JP, Chui H, Geschwind MD, Small GW, Barrio JR, Jagust W, Miller BL. Amyloid imaging in distinguishing atypical prion disease from Alzheimer disease. Neurology. 69: 283-90. PMID 17636066 DOI: 10.1212/01.Wnl.0000265815.38958.B6  0.35
2007 Josephson SA, Papanastassiou AM, Berger MS, Barbaro NM, McDermott MW, Hilton JF, Miller BL, Geschwind MD. The diagnostic utility of brain biopsy procedures in patients with rapidly deteriorating neurological conditions or dementia. Journal of Neurosurgery. 106: 72-5. PMID 17236490 DOI: 10.3171/Jns.2007.106.1.72  0.345
2007 Chang CC, Eggers SD, Johnson JK, Haman A, Miller BL, Geschwind MD. Anti-GAD antibody cerebellar ataxia mimicking Creutzfeldt-Jakob disease. Clinical Neurology and Neurosurgery. 109: 54-7. PMID 16621241 DOI: 10.1016/J.Clineuro.2006.01.009  0.348
2006 Lewis AM, Yu M, DeArmond SJ, Dillon WP, Miller BL, Geschwind MD. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease with abnormal imaging. Archives of Neurology. 63: 288-90. PMID 16476821 DOI: 10.1001/Archneur.63.2.288  0.363
2006 Rabinovici GD, Wang PN, Levin J, Cook L, Pravdin M, Davis J, DeArmond SJ, Barbaro NM, Martindale J, Miller BL, Geschwind MD. First symptom in sporadic Creutzfeldt-Jakob disease. Neurology. 66: 286-7. PMID 16434680 DOI: 10.1212/01.Wnl.0000196440.00297.67  0.318
2006 Boxer AL, Geschwind MD, Belfor N, Gorno-Tempini ML, Schauer GF, Miller BL, Weiner MW, Rosen HJ. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Archives of Neurology. 63: 81-6. PMID 16401739 DOI: 10.1001/Archneur.63.1.81  0.364
2005 Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, Serban A, Vey M, Baron H, Giles K, Miller BL, Dearmond SJ, Prusiner SB. Diagnosis of human prion disease. Proceedings of the National Academy of Sciences of the United States of America. 102: 3501-6. PMID 15741275 DOI: 10.1073/Pnas.0409651102  0.388
2004 Goldman JS, Miller BL, Safar J, de Tourreil S, Martindale JL, Prusiner SB, Geschwind MD. When sporadic disease is not sporadic: the potential for genetic etiology. Archives of Neurology. 61: 213-6. PMID 14967768 DOI: 10.1001/Archneur.61.2.213  0.39
2003 Geschwind MD, Martindale J, Miller D, DeArmond SJ, Uyehara-Lock J, Gaskin D, Kramer JH, Barbaro NM, Miller BL. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Archives of Neurology. 60: 813-6. PMID 12810484 DOI: 10.1001/Archneur.60.6.813  0.386
2003 Martindale J, Geschwind MD, De Armond S, Young G, Dillon WP, Henry R, Uyehara-Lock JH, Gaskin DA, Miller BL. Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease. Archives of Neurology. 60: 767-70. PMID 12756143 DOI: 10.1001/Archneur.60.5.767  0.42
2003 Martindale JL, Geschwind MD, Miller BL. Psychiatric and neuroimaging findings in Creutzfeldt-Jakob disease. Current Psychiatry Reports. 5: 43-6. PMID 12686001 DOI: 10.1007/S11920-003-0008-2  0.428
2002 Greicius MD, Geschwind MD, Miller BL. Presenile dementia syndromes: an update on taxonomy and diagnosis. Journal of Neurology, Neurosurgery, and Psychiatry. 72: 691-700. PMID 12023408 DOI: 10.1136/Jnnp.72.6.691  0.4
Show low-probability matches.